SSY Group (HKG:2005) said it has received production and registration approval from China's National Medical Products Administration for Benidipine Hydrochloride Tablets (8mg), according to a Monday Hong Kong bourse filing.
The product is classified as a type 4 chemical drug and is deemed to have passed consistency evaluation.
The drug is used for primary hypertension and angina pectoris.